Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Flyvbjerg

Showing results (61-70 of 284) with videos related to

Pageof 29
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2004
Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?Frans A van Nieuwenhoven, Louise J N Jensen, Allan Flyvbjerg, et al.
Journal of Clinical Periodontology|August 11, 2015
Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker ratsMorten Bay Grauballe, Jakob Appel Østergaard, Søren Schou, et al.
European Journal of Endocrinology|April 13, 2010
Alterations in circulating adiponectin levels occur rapidly after parturitionJens Fuglsang, Puk Sandager, Jan Frystyk, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional studyThor Ueland, Kim Brixen, Lis Mosekilde, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 17, 2002
Physical capacity influences the response of insulin-like growth factor and its binding proteins to trainingLars Rosendal, Henning Langberg, Allan Flyvbjerg, et al.
Diabetes|January 4, 2011
Comment on: Lin et al. (2010) Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes;59: 2247-2252Jakob Appel Ostergaard, Steffen Thiel, Troels Krarup Hansen, et al.
Anticancer Research|August 21, 2003
Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patientsHenning Grønbaek, Vasilios Tanos, Dror Meirow, et al.
Journal of Periodontology|March 4, 2006
Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki ratsCarla C Pontes Andersen, Karsten Buschard, Allan Flyvbjerg, et al.
Atherosclerosis|January 26, 2010
Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial diseaseGrazina Urbonaviciene, Jan Frystyk, Allan Flyvbjerg, et al.
European Journal of Endocrinology|December 31, 2005
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patientsLars Melholt Rasmussen, Lise Tarnow, Troels Krarup Hansen, et al.
Pageof 29

Showing results (61-70 of 284) with videos related to

Sort By:
Pageof 29
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2004
Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point?Frans A van Nieuwenhoven, Louise J N Jensen, Allan Flyvbjerg, et al.
Journal of Clinical Periodontology|August 11, 2015
Effects of TNF-α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker ratsMorten Bay Grauballe, Jakob Appel Østergaard, Søren Schou, et al.
European Journal of Endocrinology|April 13, 2010
Alterations in circulating adiponectin levels occur rapidly after parturitionJens Fuglsang, Puk Sandager, Jan Frystyk, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional studyThor Ueland, Kim Brixen, Lis Mosekilde, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 17, 2002
Physical capacity influences the response of insulin-like growth factor and its binding proteins to trainingLars Rosendal, Henning Langberg, Allan Flyvbjerg, et al.
Diabetes|January 4, 2011
Comment on: Lin et al. (2010) Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes;59: 2247-2252Jakob Appel Ostergaard, Steffen Thiel, Troels Krarup Hansen, et al.
Anticancer Research|August 21, 2003
Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patientsHenning Grønbaek, Vasilios Tanos, Dror Meirow, et al.
Journal of Periodontology|March 4, 2006
Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki ratsCarla C Pontes Andersen, Karsten Buschard, Allan Flyvbjerg, et al.
Atherosclerosis|January 26, 2010
Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial diseaseGrazina Urbonaviciene, Jan Frystyk, Allan Flyvbjerg, et al.
European Journal of Endocrinology|December 31, 2005
Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patientsLars Melholt Rasmussen, Lise Tarnow, Troels Krarup Hansen, et al.
Pageof 29